Profil bibliographique

Benjamin Carpentier

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

55Publications signalées

838Citations signalées

2Affiliations récentes

Institutions déclarées

Groupe Hospitalier de l'Institut Catholique de Lille Hôpital Saint-Vincent-de-Paul

Domaines associés

Acute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentMyeloproliferative Neoplasms: Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchHemoglobinopathies and Related Disorders

Publications récentes

2026 articleOpenAlex

Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP Cohort

Lin‐Pierre Zhao, Céline Berthon, Laurène Fenwarth, Stéphane de Botton et autres

0 citationsLeukemia

Accès ouvert 2026 articleOpenAlex

9-Year Serial CMR Monitoring of Cardiac AL Amyloidosis Regression After Teclistamab

Valentina Silvestri, Manuel Toledano, Bénédicte Hivert, Emmanuelle Bourgeois et autres

0 citationsJACC Case Reports

2026 articleOpenAlex

Characteristics and prognostic significance of myelodysplasia-related features in VEXAS syndrome

Lin-Pierre Zhao, Olivier Kosmider, Maël Heiblig, T. Moulinet et autres

3 citationsLeukemia

Accès ouvert 2025 conference-abstractOpenAlex

Real life study of ivosidenib in either monotherapy or combined with azacytidine for first line mutant IDH1 AML: A study from the french AML intergroup ALFA/filo

Pierre Péterlin, Maël Heiblig, Stéphane Morisset, Sarah Bertoli et autres

1 citationBlood

Accès ouvert 2025 conference-abstractOpenAlex

Real life treatments and outcomes of older patients aged more than 60 years with FLT3-mutated acute myeloid leukemia: Report from the multicentric french observational ALFA-PPP study

Ramy Rahmé, Emmanuel Raffoux, Lionel Adès, Stéphane de Botton et autres

0 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Real-world patterns of treatment intensity and prognostic model performance in older AML: Insights from the french ALFA-PPP cohort

Lin-Pierre Zhao, Céline Berthon, L. Fenwarth, Stéphane de Botton et autres

0 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies: Insights from a large-scale NGS-based screening study

Leïla Ben Dhia, Mathieu Wémeau, Laurène Fenwarth, Alice Marceau‐Renaut et autres

0 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Ivosidenib in refractory or relapsed IDH1-mutated Acute Myeloid Leukemia patients in real life settings: The ivoobs observational study from the french AML intergroup ALFA/filo

Maël Heiblig, Pierre Péterlin, Stéphane Morisset, Pierre‐Yves Dumas et autres

0 citationsBlood

Accès ouvert 2025 articleOpenAlex

Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies and acute leukemia: insights from a large-scale NGS-based screening study

Leïla Ben Dhia, Mathieu Wémeau, Laurène Fenwarth, Alice Marceau‐Renaut et autres

2 citationsBlood Cancer Journal

Accès ouvert 2025 articleOpenAlex

High flow oxygen for vaso-occlusive crisis: a multicentre, prospective, randomised, multi-arm, multi-stage clinical trial (OSONE)

Armand Mekontso Dessap, Anoosha Habibi, Constance Guillaud, Christian Kassasseya et autres

2 citationsBMJ Open

Accès ouvert 2025 articleOpenAlex

Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles

Laurène Fenwarth, Benjamin Podvin, Loïc Vasseur, Delphine Lebon et autres

0 citationsEuropean Journal Of Haematology

Accès ouvert 2025 articleOpenAlex

Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients

Christophe Willekens, Alexandre Bazinet, Samy Chraïbi, Álex Bataller et autres

34 citationsBlood Cancer Journal

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.